Rebecca Spalding
Reuters has hired Bloomberg News reporter Rebecca Spalding to cover mergers and acquisitions in health care, biopharmaceuticals and industrial industries.
She will be based out of New York.
“Thank you all for your kind words in the last few days! It’s a great team and I’m excited for the new challenge,” she wrote on Twitter.
Spalding was based on Boston for Bloomberg. She has written about a drug with a $2 million price tag, a Harvard professor who made $400 million in an biotechnology IPO, Blackstone’s foray into drug development, and how Cambridge, Massachusetts, came to be a magnet for the industry.
She had been at Bloomberg for nearly four years and had previously interned at Forbes.
Wall Street Journal reporter Hannah Miao is moving to Singapore to cover the China economy.…
Financial Times reporter Simon Foy is now covering European banks. He has been covering accounting for the…
Debtwire, the leading provider of global fixed income news, analysis and data for more than…
Amber Kanwar, an anchor for BNN Bloomberg in Canada, is departing at the end of…
Moody's Ratings has promoted Yvette Kantrow to senior vice president and editor in chief. She has been…
Politico reporter Clare Fieseler is leaving the news organization to take on some ocean reporting projects. She…
View Comments
You need to look into KKRs Covenant Physician Partners entity with respect to their performance vis a vis the physicians. Also examine the debt structure.